Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Severe Recurrent Aphthous Stomatitis
NCT04227314Phase 3Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Apr 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apremilast in recurrent aphthous stomatitis (RAS), sponsored by Rouen University Hospital. Started Apr 2022; status: recruiting.
02
Drugs
apremilast
03
Conditions
recurrent aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT04227314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04227314.